New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 8, 2013
08:55 EDTCLDXCelldex price target raised to $15 from $9 at Jefferies
Jefferies increased its price target on Celldex as the firm believes that the company's pipeline outlook was encouraging. The firm views Celldex as a compelling biotech play with multiple shots on goal and it maintains a Buy rating.
News For CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CLDX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use